Tony Andréani

1.9k total citations
20 papers, 1.2k citations indexed

About

Tony Andréani is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tony Andréani has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Hepatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tony Andréani's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (6 papers). Tony Andréani is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (6 papers). Tony Andréani collaborates with scholars based in France and Italy. Tony Andréani's co-authors include Raoul Poupon, Lawrence Serfaty, Olivier Chazouillères, O. Chazouillères, Catherine Johanet, Christophe Corpechot, Yves Chrétien, Ludovico Abenavoli, Nicolas Carbonell and P. Giral and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Tony Andréani

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tony Andréani France 11 977 962 307 92 91 20 1.2k
Chuan‐Mo Lee Taiwan 24 1.1k 1.1× 1.2k 1.2× 226 0.7× 52 0.6× 175 1.9× 44 1.6k
M. Chevallier France 16 659 0.7× 639 0.7× 164 0.5× 46 0.5× 30 0.3× 35 984
M.P. Manns Germany 15 1.4k 1.5× 1.7k 1.7× 215 0.7× 186 2.0× 35 0.4× 47 1.9k
Takeshi Sodeyama Japan 13 1.3k 1.3× 1.4k 1.4× 69 0.2× 87 0.9× 66 0.7× 42 1.7k
Anna Suk‐Fong Lok United States 17 1.1k 1.1× 1.1k 1.2× 95 0.3× 106 1.2× 127 1.4× 21 1.4k
C. J. Tibbs United Kingdom 19 523 0.5× 544 0.6× 199 0.6× 22 0.2× 119 1.3× 30 855
T.-H. Wang Taiwan 9 650 0.7× 687 0.7× 107 0.3× 53 0.6× 36 0.4× 11 915
Maria Lúcia Gomes Ferraz Brazil 20 992 1.0× 1.1k 1.1× 103 0.3× 65 0.7× 46 0.5× 148 1.5k
D J Pudifin South Africa 14 546 0.6× 400 0.4× 147 0.5× 283 3.1× 52 0.6× 35 1.1k
Damien Lucidarme France 16 597 0.6× 356 0.4× 309 1.0× 108 1.2× 246 2.7× 43 1.1k

Countries citing papers authored by Tony Andréani

Since Specialization
Citations

This map shows the geographic impact of Tony Andréani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Andréani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Andréani more than expected).

Fields of papers citing papers by Tony Andréani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Andréani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Andréani. The network helps show where Tony Andréani may publish in the future.

Co-authorship network of co-authors of Tony Andréani

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Andréani. A scholar is included among the top collaborators of Tony Andréani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Andréani. Tony Andréani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andréani, Tony, et al.. (2024). Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of Seven. Digestive Diseases and Sciences. 70(3). 1178–1189. 1 indexed citations
2.
Andréani, Tony. (2011). HBV-carriers: When is monitoring and surveillance sufficient? (point of view). Clinics and Research in Hepatology and Gastroenterology. 35(12). 813–818. 7 indexed citations
3.
Abenavoli, Ludovico, Christophe Corpechot, Yves Chrétien, et al.. (2009). BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID AND LONG-TERM PROGNOSIS IN PRIMARY BILIARY CIRRHOSIS. Digestive and Liver Disease. 41. S38–S39. 6 indexed citations
4.
Corpechot, Christophe, Ludovico Abenavoli, Yves Chrétien, et al.. (2008). Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 48(3). 871–877. 417 indexed citations
5.
Andréani, Tony, et al.. (2007). Chronic Hepatitis B Virus Carriers in the Immunotolerant Phase of Infection: Histologic Findings and Outcome. Clinical Gastroenterology and Hepatology. 5(5). 636–641. 86 indexed citations
6.
Fartoux, Lætitia, Lionel Arrivé, Tony Andréani, et al.. (2005). Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. Gastroentérologie Clinique et Biologique. 29(12). 1213–1219. 10 indexed citations
7.
Serfaty, Lawrence, Tony Andréani, P. Giral, et al.. (2001). Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. Journal of Hepatology. 34(3). 428–434. 245 indexed citations
8.
Serfaty, Lawrence, Dominique Thabut, Fabien Zoulim, et al.. (2001). Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results of a pilot study. Hepatology. 34(3). 573–577. 63 indexed citations
9.
Serfaty, Lawrence, Tony Andréani, H. Fontaine, et al.. (2000). Sequential treatment with lamivudine and interferon in patients with chronic hepatitis B non responder to interferon alone. Journal of Hepatology. 32. 103–103. 1 indexed citations
10.
11.
Serfaty, Lawrence, O. Chazouillères, Jean–Michel Pawlotsky, et al.. (1996). Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology. 110(1). 291–295. 81 indexed citations
12.
Abergel, Armand, et al.. (1995). Treatment of chronic hepatitis C with interferon alpha before pregnancy. Gastroenterology. 108(4). A1075–A1075.
13.
Youinou, Pierre, et al.. (1995). [Association of Gougerot-Sjögren syndrome and viral hepatitis C. Apropos of 6 cases].. PubMed. 146(4). 247–50. 17 indexed citations
14.
Serfaty, Lawrence, Philippe Giral, Alain Loria, et al.. (1994). Factors predictive of the response to interferon in patients with chronic hepatitis C. Journal of Hepatology. 21(1). 12–17. 80 indexed citations
15.
Couroucé, A.M., V. Massari, M. Maniez, et al.. (1993). Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. European Journal of Clinical Microbiology & Infectious Diseases. 12(9). 668–672. 8 indexed citations
16.
Naveau, Sylvie, Pierre Bédossa, Lee Turner, et al.. (1989). Successful ablation of a large fibrovascular polyp of the esophagus by endoscopic Nd:YAG laser therapy. Gastrointestinal Endoscopy. 35(3). 254–256. 11 indexed citations
17.
Chazouillères, O., Tony Andréani, Claire Legendre, R Poupon, & F Darnis. (1986). [Nodular regenerative hyperplasia of the liver and primary biliary cirrhosis. A fortuitous association?].. PubMed. 10(11). 764–6. 5 indexed citations
18.
Andréani, Tony, C Buffet, & Etienne Jp. (1986). [Jaundice caused by neoplastic obstruction. Role of non-surgical palliative treatment].. PubMed. 10(4). 308–18. 2 indexed citations
19.
Andréani, Tony, et al.. (1984). [Subcutaneous abdominal emphysema and pneumoscrotum after endoscopic resection of rectal polyps].. PubMed. 8(4). 387–387. 3 indexed citations
20.
Andréani, Tony, Y. Le Charpentier, Jean‐Claude Brouet, et al.. (1983). ACQUIRED IMMUNODEFICIENCY WITH INTESTINAL CRYPTOSPORIDIOSIS: POSSIBLE TRANSMISSION BY HAITIAN WHOLE BLOOD. The Lancet. 321(8335). 1187–1191. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuan‐Mo Lee Breakdown of academic impact, for papers by M. Chevallier Breakdown of academic impact, for papers by M.P. Manns Breakdown of academic impact, for papers by Takeshi Sodeyama Breakdown of academic impact, for papers by Anna Suk‐Fong Lok Breakdown of academic impact, for papers by C. J. Tibbs Breakdown of academic impact, for papers by T.-H. Wang Breakdown of academic impact, for papers by Maria Lúcia Gomes Ferraz Breakdown of academic impact, for papers by D J Pudifin Breakdown of academic impact, for papers by Damien Lucidarme
Rankless by CCL
2026